Ignite Creation Date:
2024-05-06 @ 12:35 PM
Last Modification Date:
2024-10-26 @ 1:01 PM
Study NCT ID:
NCT03801304
Status:
COMPLETED
Last Update Posted:
2022-05-12
First Post:
2019-01-07
Brief Title:
Trial to Evaluate Safety and Efficacy of Vinorelbine With Metronomic Administration in Combination With Atezolizumab as Second-line Treatment for Patients With Stage IV Non-small Cell Lung Cancer
Sponsor:
University Hospital Brest
Organization:
University Hospital Brest
Organization Data
Organization:
University Hospital Brest
Class:
OTHER
Study ID:
29BRC18-0005 VinMetAtezo
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University Hospital Brest
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pierre Fabre Medicament | INDUSTRY |
| Groupe Français de Pneumo-Cancérologie | UNKNOWN |
| Roche Farma SA | INDUSTRY |